PainRELIEFNCT01719055
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
An observational study of Pain, run by Boston Scientific Corporation at 118 sites in 16 countries.
Trial summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use and - To evaluate the economic value and technical performance of Boston Scientific… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pain
- What is being tested?
- neurostimulation system
- Type of treatment
- Medical device
- How many people
- 4,800 participants
- Where
- 118 sitesin 16 countries
- Study dates
- 19 Nov 2012to May 2035
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subjects who exhibit an on-label indication for neurostimulation to relieve chronic intractable pain, according to the Instructions for Use, as applicable in each country or region
Who may be able to join
- Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
- Signed a valid, IRB/EC-approved informed consent form
- 18 years of age or older
Who cannot join
- Contraindicated for Boston Scientific neurostimulation system
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Trial locations and contacts
118 sites in 16 countries. Contact the study team or a site near you to ask about taking part.
118 sites in 16 countries
United States67 sites, 12 recruiting
- Terminated
Albany Medical Center
Albany, New York, 12208
- Terminated
Michigan Pain Specialists
Ann Arbor, Michigan, 48108
- Terminated
Balcones Pain Consultants
Austin, Texas, 78745
- Terminated
Washington Center for Pain Management
Bellevue, Washington, 98004
- Recruiting
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Beth Israel Deaconess Medical Center
Brookline, Massachusetts, 02445
- Terminated
Comprehensive Pain Management Center
Campbell, California, 95008
- Terminated
Coastal Research Institute
Carlsbad, California, 92009
- Terminated
Medical University of South Carolina
Charleston, South Carolina, 29425
- Terminated
Midwest Pain Center
Chesterfield, Missouri, 63005
- Terminated
Saint Louis Pain Consultants
Chesterfield, Missouri, 63017
- Terminated
Northwestern Memorial Hospital - Neurosurgery Outpatient Clinic
Chicago, Illinois, 60611
- Terminated
Chicago Anesthesia Pain Specialists
Chicago, Illinois, 60657
- Recruiting
Orlando Health Neuroscience Institute, Inc
Clermont, Florida, 34711
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
South Lake Pain Institute, Inc
Clermont, Florida, 34711
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Completed
Case Western Reserve University
Cleveland, Ohio, 44106
- Terminated
Ohio State University Medical Center
Columbus, Ohio, 43203
- Recruiting
Institute of Precision Pain Medicine
Corpus Christi, Texas, 78414
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Withdrawn
Neuroscience Associates of Northern Kentucky
Crestview Hills, Kentucky, 41017
- Terminated
Bux Pain Management
Danville, Kentucky, 40422
- Recruiting
Pacific Sports and Spine, LLC
Eugene, Oregon, 97401
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Global Scientific Innovations - Advanced Pain Care Clinic
Evansville, Indiana, 47714
- Terminated
Insight Institute of Neurosurgery & Neuroscience
Flint, Michigan, 48507
- Terminated
Florence Neurosurgery and Spine
Florence, South Carolina, 29506
- Terminated
Summit Research Institute
Fort Wayne, Indiana, 46825
- Terminated
Pain Medicine Associates, Inc.
Fountain Valley, California, 92708
- Recruiting
University of Florida Shands Hospital
Gainesville, Florida, 32608
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Advanced Pain Management Appleton
Greenfield, Wisconsin, 53221
- Recruiting
PCPMG Clinical Research Unit, LLC
Greenville, South Carolina, 29601
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Withdrawn
Goodman Campbell Brain and Spine
Greenwood, Indiana, 46143
- Recruiting
Denver Back Pain Specialists
Greenwood Village, Colorado, 80111
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Carolinas Research Institute, PLLC
Huntersville, North Carolina, 28078
- Terminated
Jackson Anesthesia Pain Center, LLC
Jackson, Mississippi, 39202
- Terminated
Louis J. Raso, MD, PA
Jupiter, Florida, 33477
- Withdrawn
EvergreenHealth Pain Care
Kirkland, Washington, 98034
- Withdrawn
Hope Research Institute
Las Vegas, Nevada, 89106
- Terminated
KC Pain Centers
Lee's Summit, Missouri, 64086
- Terminated
Research Medical Center
Lenexa, Kansas, 66214
- Terminated
Advanced Interventional Pain Management and Research Clinic, Inc.
Miami Gardens, Florida, 33169
- Withdrawn
West Virginia University Hospitals
Morgantown, West Virginia, 26506
- Terminated
American Health Network of Indiana, LLC
Muncie, Indiana, 47304
- Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana, 70115
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
New York Presbyterian Hospital
New York, New York, 10065
- Terminated
Spine Works Institute
North Richland Hills, Texas, 76182
- Terminated
Channel Research
Pawleys Island, South Carolina, 29585
- Terminated
Physicians Research Group, LLC
Phoenix, Arizona, 85016
- Terminated
Hope Research Institute
Phoenix, Arizona, 85018
- Terminated
Raleigh Neurology Associates, P.A.
Raleigh, North Carolina, 27607
- Terminated
University of Rochester
Rochester, New York, 14618
- Terminated
Spine Team Texas
Rockwall, Texas, 75032
- Terminated
Metropolitan Pain Management Consultants Inc.
Sacramento, California, 95821
- Withdrawn
Huntley Pain Specialists
San Diego, California, 92108
- Terminated
Orthopedic Research Foundation
Savannah, Georgia, 31405
- Terminated
Swedish Neuroscience Institute
Seattle, Washington, 98122
- Recruiting
Willis-Knighton River Cities Clinical Research Center
Shreveport, Louisiana, 71105
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Withdrawn
JM Clinical Research
South Miami, Florida, 33143
- Withdrawn
Pain Care, LLC
Stockbridge, Georgia, 30281
- Terminated
Tallahassee Neurological Clinic, PA
Tallahassee, Florida, 32308
- Recruiting
Montefiore Medical Center
The Bronx, New York, 10461
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Conejo Pain Specialists
Thousand Oaks, California, 91362
- Terminated
University of Toledo Medical Center
Toledo, Ohio, 43614
- Recruiting
Fox Chase Pain Management
Trevose, Pennsylvania, 19053
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Completed
Banner University Medical Center
Tucson, Arizona, 85724
- Terminated
Precision Spine Care
Tyler, Texas, 75701
- Terminated
Spine and Skeletal Pain Medicine
Utica, New York, 13502
- Terminated
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, 27103
- Terminated
Forest Health Medical Center
Ypsilanti, Michigan, 48198
Spain10 sites, 4 recruiting
- Recruiting
Hospital General de Ciudad Real
Ciudad Real
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Hospital La Paz
Madrid
- Terminated
Hospital La Princesa
Madrid
- Recruiting
Hospital Puerta de Hierro
Madrid
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Withdrawn
Hospital Universitario Infanta Elena
Madrid
- Recruiting
Clinica Universidad de Navarra
Pamplona
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Active, not recruiting
Hospital Donostia
San Sebastián
- Terminated
H. Marques De Valdecilla
Santander
- Terminated
Hospital Virgen De La Salud
Toledo
- Recruiting
Hospital General de Valencia
Valencia
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
Australia8 sites, 1 recruiting
- Withdrawn
Interventus Pain Specialists
Auchenflower
- Terminated
Hunter Clinical Research
Broadmeadow
- Terminated
Hunter Pain Clinic
Broadmeadow
- Terminated
Green Lizard Science
Claremont
- Terminated
Sydney Spine and Pain Pty Ltd
Hurstville
- Terminated
Sunshine Coast Clinical Research
Noosa
- Terminated
Pain Matrix
Waurn Ponds
- Recruiting
Pain Medicine of South Australia
Wayville
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
United Kingdom7 sites, 5 recruiting
- Recruiting
Basildon and Thurrock University Hospitals NHS
Basildon
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
Southmead Hospital Bristol
Bristol
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
The General Infirmary
Leeds
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Chelsea and Westminster Hospital
London
- Recruiting
St. Bartholomews Hospital
London
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
James Cook University Hospital
Middlesbrough
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Royal National Orthopaedic Hospital
Stanmore
Germany6 sites, 3 recruiting
- Recruiting
Universitatsklinik Charite Berlin
Berlin
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
University KH Bonn
Bonn
- Terminated
Uniklinik Köln
Cologne
- Recruiting
Uniklinik Köln
Cologne
Boston Scientific Clinical Research, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
Universitaetsklinikum Dusseldorf
Düsseldorf
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Algesiologikum
München
Japan4 sites
- Terminated
Kobe University Hospital
Kobe
- Terminated
Hyogo College of Medicine Hospital
Nishinomiya-shi
- Terminated
Okayama University Hospital
Okayama
- Terminated
Sakai Hospital Kinki University Faculty of Medicine
Sakaishi
Canada3 sites, 2 recruiting
- Terminated
London Health Sciences Centre
London
- Recruiting
Hopital de Enfant-Jesus
Québec
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Recruiting
Regina General Hospital
Regina
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
Colombia2 sites
- Withdrawn
Fundacion Clinica Valle del Lili
Cali
- Terminated
Fundacion Cardiovascular de Colombia Floridablanca
Floridablanca
Israel2 sites
- Terminated
Sheba Medical Center
Ramat Gan
- Terminated
Tel Aviv Sourasky Medical Center
Tel Aviv
Italy2 sites, 1 recruiting
- Recruiting
Fondazione Salvatore Maugeri IRCCS
Pavia
Boston Scientific Clinical Research Manager, 855-213-9890, BSNClinicalTrials@bsci.com
- Terminated
Azienda Ospedaliero Universitaria Pisana
Pisa
Argentina1 site
- Terminated
CENIT Centro de Neurociencias, Investigacion y Tratamiento
Buenos Aires
About this study
Official title: A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Read the detailed description
The study is a prospective, multi-center, global, post-market study of Boston Scientific neurostimulation systems for pain.
The study treatment will consist of neurostimulation trial therapy with any commercially approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects with a successful trial outcome, may progress to permanent implant of a neurostimulation system. Individualization of neurostimulation therapy for pain will be determined according to investigator discretion and site routine care, and in accordance with inclusion and exclusion criteria.
- Conditions
- Pain
- Being tested
- neurostimulation system
- Keywords
- stimulation, implantable, pulse generator, back pain, chronic pain, leg pain
- Medical subject headings
- Pain, Back Pain, Chronic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
neurostimulation systemDevice
Trial stimulation period, followed by permanent implant of a neurostimulation system for subjects with a positive trial outcome
| Study group | Role | What they receive |
|---|---|---|
| Boston Scientific SCS Systems | Subjects permanently implanted with a Boston Scientific neurostimulation systems Receives: Device: neurostimulation system |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Nov 2012 (estimated)
- Study start19 Nov 2012
- Primary completionMay 2035 (estimated)
- Study completionMay 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- More trials run by Boston Scientific CorporationThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Boston Scientific Corporation
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Natalie Bloom Lyons, Study director, Boston Scientific Corporation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01719055
- Sponsor's protocol ID
- A7007
- Other IDs
- 90876777
- Acronym
- RELIEF
- Status last verified
- Oct 2026
- First submitted
- 30 Oct 2012
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JF, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J, Prud'Homme M, Phillips GM, Smith SG, Ibrahim M, Willoughby CD, Obray JB, Gupta M, Paez J, Berg AP, Harrison NJ, Maino P, Mambalam P, McCarty M, Towlerton G, Love-Jones S, Ahmed S, Lee A, Shah B, Goor-Aryeh I, Russo MA, Varela N, Phelps JB, Cid J, Fernandez T, Perez-Hernandez C, Keehn D, Rosenow JM, Haider N, Parrent AG, Lawrence MM, Georgius P, Demartini L, Mendiola A, Mehta V, Thoma R, Israel AF, Carolis G, Bhatia S, Green M, Villarreal A, Crooks MT, Gwinn RP, Pilitsis JG, Sato H, Vega SM, Hillegass MG, Carnes P, Scherer C, Brill S, Yu J, Brennan JJ, Gatzinsky K, Navani A, Snook LT Jr, Bujedo BM, Andres Ares J, Murillo A, Trobridge AT, Assil K, Shah J, McLeod C, Buwembo J, Coster O, Miller N, Sanapati M, Mikhael M, Przkora R, Sukenaga N, Raso LJ, Calodney AK, Caceres Jerez LE, Uchiyama T, Kallewaard JW, Chandler B, Piedimonte F, Candido KD, Weaver TE, Agari T, Holthouse D, Woon R, Patel N, Lechleiter K, Jain R. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain. Pain Manag. 2023 Feb;13(2):115-127. doi: 10.2217/pmt-2022-0091. Epub 2023 Jan 24.
PubMed 36691862
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- ClinicalTrials.gov ID
- NCT01719055
- Acronym / sponsor ID
- RELIEF / A7007
- Conditions
- Pain
- Keywords
- stimulation, implantable, pulse generator, back pain, chronic pain, leg pain
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 4,800 participants (estimated)
- Lead sponsor
- Boston Scientific CorporationIndustry (pharma, biotech, devices)
- Study start
- 19 Nov 2012 (actual)
- Primary completion
- May 2035 (estimated)
- Study completion
- May 2035 (estimated)
- First posted
- 1 Nov 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Detailed description
The study is a prospective, multi-center, global, post-market study of Boston Scientific neurostimulation systems for pain.
The study treatment will consist of neurostimulation trial therapy with any commercially approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects with a successful trial outcome, may progress to permanent implant of a neurostimulation system. Individualization of neurostimulation therapy for pain will be determined according to investigator discretion and site routine care, and in accordance with inclusion and exclusion criteria.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Boston Scientific SCS Systems | – | Device: neurostimulation systemSubjects permanently implanted with a Boston Scientific neurostimulation systems |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subjects who exhibit an on-label indication for neurostimulation to relieve chronic intractable pain, according to the Instructions for Use, as applicable in each country or region
Key inclusion criteria (3 listed)
- Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
- Signed a valid, IRB/EC-approved informed consent form
- 18 years of age or older
Key exclusion criteria (2 listed)
- Contraindicated for Boston Scientific neurostimulation system
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| neurostimulation systemTrial stimulation period, followed by permanent implant of a neurostimulation system for subjects with a positive trial outcome | Device | Boston Scientific SCS Systems |
Primary outcome
Not reported in the source record.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
- Derived from this study: PubMed 36691862Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JF, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J, Prud'Homme M, Phillips GM, Smith SG, Ibrahim M, Willoughby CD, Obray JB, Gupta M, Paez J, Berg AP, Harrison NJ, Maino P, Mambalam P, McCarty M, Towlerton G, Love-Jones S, Ahmed S, Lee A, Shah B, Goor-Aryeh I, Russo MA, Varela N, Phelps JB, Cid J, Fernandez T, Perez-Hernandez C, Keehn D, Rosenow JM, Haider N, Parrent AG, Lawrence MM, Georgius P, Demartini L, Mendiola A, Mehta V, Thoma R, Israel AF, Carolis G, Bhatia S, Green M, Villarreal A, Crooks MT, Gwinn RP, Pilitsis JG, Sato H, Vega SM, Hillegass MG, Carnes P, Scherer C, Brill S, Yu J, Brennan JJ, Gatzinsky K, Navani A, Snook LT Jr, Bujedo BM, Andres Ares J, Murillo A, Trobridge AT, Assil K, Shah J, McLeod C, Buwembo J, Coster O, Miller N, Sanapati M, Mikhael M, Przkora R, Sukenaga N, Raso LJ, Calodney AK, Caceres Jerez LE, Uchiyama T, Kallewaard JW, Chandler B, Piedimonte F, Candido KD, Weaver TE, Agari T, Holthouse D, Woon R, Patel N, Lechleiter K, Jain R. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain. Pain Manag. 2023 Feb;13(2):115-127. doi: 10.2217/pmt-2022-0091. Epub 2023 Jan 24.
Related trials for Pain
Not yet recruiting
Digital Use, 24-Hour Movement Behaviors, and Myofascial Release in University Students With Neck Pain
Forward Head Posture, Chronic Nonspecific Neck Pain
Recruiting
Effects of Virtual Reality Exergames Versus Spinal Manipulation in Chronic Nonspecific Low Back Pain
Chronic Nonspecific Low-back Pain, CNSLBP
Recruiting
Dietary Intervention for Migraine Relief
Migraine
RecruitingPhase 4
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
Laparoscopic Surgery, Visceral Pain, Postoperative
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Natalie Bloom Lyons study director
Boston Scientific Corporation
118 sites in 16 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pain, run by Boston Scientific Corporation at 118 sites in 16 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 118 sites in United States, Spain, Australia, United Kingdom, Germany and 11 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Thanh Hoang, MS (855-213-9890, BSNClinicalTrials@bsci.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01719055, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026; AzTrials last refreshed its copy on 31 Oct 2026.